Ocuphire Pharma
percent of subjects with or worsening in binocular of steps | Ocuphire Pharma
Company
Deck Type
Deck date
January 2023
Slide
17 of 31
Similar slides by Ocuphire Pharma
See diffirences between slides (animation)
Investor Presentation
August 2023
percent of subjects with step improvement in from | Ocuphire Pharma
Results
January 2023
waterfall by subject binocular change in at week | Ocuphire Pharma
Results
January 2023
percent of subjects with binocular worsening in of step | Ocuphire Pharma
Results
January 2023
percent of subjects with step improvement in from | Ocuphire Pharma
Related slides by other companies
Equillium
Investor Presentation
December 2023
clinically validated in severe dermatological disease | Equillium
Equillium
Investor Presentation
August 2023
clinically validated in severe dermatological disease | Equillium
Equillium
Investor Presentation
November 2023
clinically validated in severe dermatological disease | Equillium
Equillium
Investor Presentation
February 2024
clinically validated in severe dermatological disease | Equillium
Other recent decks by Ocuphire Pharma
See all presentations (10 decks)
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
May 2023
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights